Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.94 by 9.57 percent. This is a 11.46 percent decrease over earnings of $0.96 per share from the same period last year. The company reported quarterly sales of $42.30 million which missed the analyst consensus estimate of $51.08 million by 17.19 percent. This is a 15.26 percent decrease over sales of $49.92 million the same period last year.
Eagle Pharmaceuticals Q4 EPS $0.85 Misses $0.94 Estimate, Sales $42.30M Miss $51.08M Estimate
Eagle Pharmaceuticals (NASDAQ:EGRX) reported quarterly earnings of $0.85 per share which missed the analyst consensus estimate of $0.94 by 9.57 percent. This is a 11.46 percent decrease over earnings of $0.96 per share
